HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Phase 2 Randomized Trial To Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: Clinical Trial Update.

Abstract
Preliminary results from our study provide further evidence that low-intensity extracorporeal shockwave therapy is a safe and effective treatment modality for erectile dysfunction. Our treatment protocol with shockwaves given to men over 2 wk had the most robust effect.
AuthorsJonathan E Katz, Manuel L Molina, Raul Clavijo, Nachiketh Soodana Prakash, Ranjith Ramasamy
JournalEuropean urology focus (Eur Urol Focus) Vol. 4 Issue 3 Pg. 336-337 (04 2018) ISSN: 2405-4569 [Electronic] Netherlands
PMID30025713 (Publication Type: Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Testosterone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Clinical Protocols
  • Erectile Dysfunction (epidemiology, psychology, therapy)
  • Extracorporeal Shockwave Therapy (methods)
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Middle Aged
  • Testosterone (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: